Stockreport

Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors [Yahoo! Finance]

Personalis, Inc.  (PSNL) 
Last personalis, inc. earnings: 3/25 04:01 pm Check Earnings Report
PDF announced the publication of a new study in npj Precision Oncology highlighting the power of its ultrasensitive molecular residual disease (MRD) assay, NeXT Personal®, i [Read more]